Steward Partners Investment Advisory’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-667
Closed -$23.3K 3457
2023
Q2
$23.3K Hold
667
﹤0.01% 2217
2023
Q1
$23.4K Sell
667
-333
-33% -$12K ﹤0.01% 2180
2022
Q4
$34.7K Hold
1,000
﹤0.01% 1980
2022
Q3
$34K Sell
1,000
-250
-20% -$9.29K ﹤0.01% 1972
2022
Q2
$43K Sell
1,250
-167
-12% -$6.21K ﹤0.01% 1878
2022
Q1
$62K Sell
1,417
-2,939
-67% -$127K ﹤0.01% 1817
2021
Q4
$216K Sell
4,356
-38
-0.9% -$1.97K ﹤0.01% 1282
2021
Q3
$234K Buy
4,394
+411
+10% +$22.7K ﹤0.01% 1209
2021
Q2
$231K Sell
3,983
-705
-15% -$40.1K ﹤0.01% 1442
2021
Q1
$269K Buy
4,688
+1,359
+41% +$83.2K ﹤0.01% 1151
2020
Q4
$193K Buy
3,329
+1,654
+99% +$89K ﹤0.01% 1088
2020
Q3
$84K Buy
+1,675
New +$80.8K ﹤0.01% 1287

Other funds holding HEAL

Steward Partners Investment Advisory's HEAL Position: Q3 2023 in Review

Steward Partners Investment Advisory sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q3 2023, closing a stake of 667 shares — an estimated $23.3K sold.

Steward Partners Investment Advisory first reported a position in HEAL in Q3 2020 and held it in 12 quarters. The position peaked at $269K in Q1 2021. 49 funds tracked by Wall St. Rank hold HEAL as of Q3 2023.

  • Steward Partners Investment Advisory reported no remaining Global X Funds Global X HealthTech ETF position as of Q3 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 667 Global X Funds Global X HealthTech ETF shares in Q3 2023, an estimated $23.3K.
  • Steward Partners Investment Advisory first reported a position in Global X Funds Global X HealthTech ETF in Q3 2020 and held it in 12 quarters.
  • Steward Partners Investment Advisory's Global X Funds Global X HealthTech ETF position peaked at $269K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q3 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.